Fund · iShares MSCI Denmark ETF · measured from SEC filings
EDEN holdings
EDEN reports 44 holdings and behaves like 12.4 equally weighted ones, computed from its SEC Form N-PORT filing for 2026-05-31. The fact sheet publishes the first number; this page computes the second, and traces it across 27 quarters of filings.
Measured concentration
as of 2026-05-31Read this figure with the following in mind
5.2% of net assets is securities-lending cash collateral, excluded from the figure; counted as filed the fund would read 12.4
The figure below is what the filing says, published unchanged. What it may not do is sit beside a plain long-only fund and be read as the same quantity. How comparability is decided.
Computed by this site from the fund's SEC Form N-PORT filing; what the measure does not tell you · every fund in one table · hold it with other funds? X-ray the mix. Pricing: 14.08% at a quoted market price (level 1), 3 issuer countries.
What stands out
as of 2026-05-31EDEN's largest investment is Novo Nordisk A S at 21.36% of net assets. DSV Panalpina A S and Danske Bank A S follow; the three together are 40.22%. Ten companies are 66.39% of the fund; the other 34 share the rest. Among the 721 equity funds measured here, EDEN behaves like 12.4 holdings against a median of 42.4 — 3.4 times more concentrated than the median. Across 27 quarterly filings EDEN has held roughly steady since 2019-11-30 (13.1 then, 12.4 now). Between the 2026-02-28 and 2026-05-31 filings 3 positions were added and 1 dropped; 6.1% of the weight moved.
Each sentence is read from the fund's own SEC filing; the class median is computed across the comparable equity funds on this site. Nothing here is a view on the fund.
Every filing since 2019
27Between 2019-11-30 and 2026-05-31, EDEN went from behaving like 13.1 equally weighted positions to 12.4 — 5% fewer, while its top ten went from 66.15% to 66.39% of net assets. Read across the funds on the concentration-over-time table.
| Period | Holdings | Effective | Top 10 | Largest |
|---|---|---|---|---|
| 2026-05-31 | 44 | 12.4 | 66.39% | 21.67% |
| 2026-02-28 | 42 | 15.2 | 63.49% | 17.37% |
| 2025-11-30 | 43 | 12.6 | 64.71% | 22.34% |
| 2025-08-31 | 43 | 11.4 | 65.82% | 24.51% |
| 2025-05-31 | 43 | 12.1 | 64.53% | 23.32% |
| 2025-02-28 | 46 | 15.7 | 57.83% | 19.45% |
| 2024-11-30 | 45 | 13.5 | 59.26% | 22.28% |
| 2024-08-31 | 47 | 13.8 | 59.65% | 22.33% |
Earlier filings (19 more, back to 2019-11-30)
| Period | Holdings | Effective | Top 10 | Largest |
|---|---|---|---|---|
| 2024-05-31 | 48 | 13.5 | 58.53% | 22.91% |
| 2024-02-29 | 47 | 13.1 | 61.27% | 23.21% |
| 2023-11-30 | 49 | 12 | 61.36% | 24.92% |
| 2023-08-31 | 49 | 11.4 | 62.34% | 25.6% |
| 2023-05-31 | 49 | 11.2 | 64.7% | 25.52% |
| 2023-02-28 | 49 | 11.5 | 64.63% | 24.87% |
| 2022-11-30 | 50 | 10.8 | 66.35% | 25.94% |
| 2022-08-31 | 50 | 12.3 | 64.63% | 23.74% |
| 2022-05-31 | 51 | 11.1 | 65.8% | 25.77% |
| 2022-02-28 | 51 | 12.3 | 66.49% | 23.21% |
| 2021-11-30 | 50 | 11.7 | 65.95% | 24.28% |
| 2021-08-31 | 49 | 10.7 | 69.29% | 25.23% |
| 2021-05-31 | 50 | 12.9 | 66.78% | 21.38% |
| 2021-02-28 | 47 | 12.6 | 66.23% | 22.43% |
| 2020-11-30 | 48 | 13 | 67.62% | 20.72% |
| 2020-08-31 | 47 | 14.9 | 65.49% | 18.41% |
| 2020-05-31 | 46 | 12.1 | 68.79% | 23.02% |
| 2020-02-29 | 45 | 12.5 | 67.68% | 22.69% |
| 2019-11-30 | 47 | 13.1 | 66.15% | 21.78% |
One row per filed reporting period, newest first, read from EDGAR. Quarterly because that is the public filing cadence. Rows marked * are published but held out of the comparison above; the methodology page says when and why.
As filed, collateral included
5.25% collateralEDEN's filing lists 45 positions including 5.25% of net assets in securities-lending cash collateral. Counted as filed the fund reads 12.4 effective holdings with a top ten of 68.15%; on its own investments — the figure above — it reads 12.4 with a top ten of 66.39%. The collateral is matched by a liability and is not a holding the fund chose; since 2026-09-18 every figure on this site sets it aside (methodology). Both numbers are in the data.
Largest positions, as filed
as of 2026-05-31The 15 largest of 44 positions in EDEN's Form N-PORT, weight as a share of net assets, securities-lending collateral excluded. Every position, every quarter: EDEN.csv.gz.
| # | Position | Weight | Cumulative |
|---|---|---|---|
| 1 | NOVO NORDISK A/S | 21.67% | 21.7% |
| 2 | DSV A/S | 11.36% | 33.0% |
| 3 | DANSKE BANK A/S | 7.79% | 40.8% |
| 4 | VESTAS WIND SYSTEMS A/S | 5.24% | 46.1% |
| 5 | NOVOZYMES A/S | 4.42% | 50.5% |
| 6 | GENMAB A/S | 3.84% | 54.3% |
| 7 | Oersted A/S | 3.57% | 57.9% |
| 8 | CARLSBERG A/S | 3.28% | 61.2% |
| 9 | A.P. MOELLER - MAERSK A/S | 2.66% | 63.8% |
| 10 | NKT A/S | 2.55% | 66.4% |
| 11 | TRYG A/S | 2.23% | 68.6% |
| 12 | A.P. MOELLER - MAERSK A/S | 2.06% | 70.7% |
| 13 | Pandora A/S | 1.93% | 72.6% |
| 14 | COLOPLAST A/S | 1.88% | 74.5% |
| 15 | RINGKJOEBING LANDBOBANK. AKTIESELSKAB | 1.88% | 76.4% |
By country of issuer
as of 2026-05-31Share of EDEN's own investments by the issuer country the filer reported (incorporation, not revenue). Each country links to every fund that holds it.
| Country | Share |
|---|---|
| Denmark | 99.04% |
| United Kingdom | 0.92% |
| United States | 0.04% |
Returns the fund reported
2019-09 – 2026-05Monthly total returns from Item B.5 of EDEN's own filings, 81 months on record. Not computed here and not from a price feed.
Cross-checked against a series computed separately from prices: median difference — percentage points over 0 months, which is roughly the distributions. Every month with the filing it came from: EDEN.json · all funds.
Who borrows EDEN's shares
2026-05-31The fund lends its holdings, and Item B.4.a of the filing names every firm holding them. At 2026-05-31, $10m was out to 4 borrowers, 5.13% of net assets. The largest, MORGAN STANLEY & CO LLC, held 66.5% of it.
| Borrower | On loan | Share of the loan |
|---|---|---|
| MORGAN STANLEY & CO LLC | $7m | 66.5% |
| GOLDMAN SACHS & CO. | $2m | 14.6% |
| BofA Securities, Inc. | $1m | 10.2% |
| STATE STREET BANK & TRUST COMPANY | $894,329 | 8.6% |
Cash collateral reported against the loan: 5.25% of net assets, 102.4% of the amount lent. That is a floor on the collateral, not the whole of it — collateral the fund does not hold as a position is not in this filing, so a figure under 100% is not evidence of under-collateralisation. How that figure behaves across all funds. Every quarter EDEN has filed, with each borrower: EDEN.json · all funds.
Since the previous filing
2026-02-28 → 2026-05-3142 positions became 44: 3 added (0.2% of the fund at the later date), 1 dropped (0.1% at the earlier date). Half the sum of all weight changes, a turnover proxy: 6.1%. Positions are matched on identifiers, so a security whose identifier changed shows as one drop and one add. Every filing of EDEN compared this way, as a feed: changes.xml · all funds: filings received.
| Largest increases | 2026-02-28 | 2026-05-31 | Largest decreases | 2026-02-28 | 2026-05-31 |
|---|---|---|---|---|---|
| NOVO NORDISK A/S | 17.37% | 21.67% | ROYAL UNIBREW A/S | 1.82% | 1.06% |
| NKT A/S | 2.27% | 2.55% | CARLSBERG A/S | 3.91% | 3.28% |
| NOVOZYMES A/S | 4.15% | 4.42% | GENMAB A/S | 4.42% | 3.84% |
| Pandora A/S | 1.67% | 1.93% | COLOPLAST A/S | 2.43% | 1.88% |
| Demant A/S | 1.03% | 1.26% | VESTAS WIND SYSTEMS A/S | 5.73% | 5.24% |
| ALK-ABELLO A/S | 1.67% | 1.84% | FLSMIDTH & CO. A/S | 1.60% | 1.19% |
New: DANISH KRONER (0.16%), OMX COP 25 JUN26 (0.01%), EURO (0.00%). Gone: cBrain A/S (0.09%).
Asset categories and pricing
as of 2026-05-31| Asset category (as filed) | Share of investments |
|---|---|
| equity EC | 94.74% |
| short-term investment STIV | 5.10% |
| unknown unknown | 0.16% |
14.1% of EDEN is carried at a quoted market price (fair-value level 1). Categories and levels are the filer's, from Form N-PORT; what a low level-1 share does and does not mean is in the measure's page.
Derivative exposure and counterparties
as of 2026-05-31A position count cannot describe a fund that uses derivatives, because a swap is filed at its unrealised gain, not its exposure. These are the notionals the fund itself reported, against net assets of $203M. Notional of an interest-rate or currency swap is not equity exposure.
Full detail for every fund that files derivatives: leverage.json (CC BY 4.0).
Neighbours by effective holdings, equity funds
10Every measured equity fund lined up by how many holdings it behaves like; these sit either side of EDEN (12.4). Same filings, same arithmetic. Position in this list says nothing about which fund is better.
| Fund | Reports | Behaves like | Top ten | As of |
|---|---|---|---|---|
| EWH iShares MSCI Hong Kong ETF | 31 | 12.1 | 66.65% | 2026-05-31 |
| EPHE iShares MSCI Philippines ETF | 38 | 12.1 | 61.95% | 2026-05-31 |
| VDE Vanguard Energy Index Fund | 106 | 12.3 | 63.95% | 2026-05-31 |
| LIT Global X Lithium and Battery Tech ETF | 41 | 12.3 | 66.07% | 2026-07-31 |
| EWN iShares MSCI Netherlands ETF | 57 | 12.3 | 60.63% | 2026-05-31 |
| AKRE Akre Focus ETF | 18 | 12.7 | 80.84% | 2026-07-31 |
| OIH VanEck Oil Services ETF | 25 | 12.8 | 70.6% | 2026-06-30 |
| FDIS Fidelity MSCI Consumer Discretionary Index ETF | 247 | 13 | 54.83% | 2026-07-31 |
| EWI iShares MSCI Italy ETF | 28 | 13 | 71.25% | 2026-05-31 |
| URA Global X Uranium ETF | 66 | 13.1 | 63.33% | 2026-07-31 |
Essays that examine EDEN
0Mentions are detected across the full text of every article, so an appearance may be a passing comparison rather than the subject. Nothing here is a recommendation to buy or sell — see the disclaimer.